# RANOLAZINE
> **ANDA212889** · Abbreviated New Drug Application (Generic) · Sponsor: RISING · Approved 2021-01-28
## Drug
- **FDA Application Number:** ANDA212889
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RANOLAZINE
- **Generic name:** Ranolazine
- **Active ingredients:** RANOLAZINE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** RISING
- **First approval:** 2021-01-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212889)
---
*MORVS · CC0 1.0*